1. Stocks
  2. Alivus Life Sciences Ltd.
  3. Swot
swot-logo

Alivus Life Sciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Alivus Life Sciences Ltd. has 13 Strengths, 6 Weaknesses, 4 Opportunities and 4 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Consistent Highest Return Stocks over Five Years - Nifty500

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over 1 Year

Expensive Performers (DVM)

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Company with No Debt

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Company with Zero Promoter Pledge

Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Degrowth in Revenue and Profit

Weak Momentum: Price below Short, Medium and Long Term Averages

Top Losers

Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Mutual Funds Increased Shareholding in Past Month

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Big Deal (Insider and SAST) sells last month greater than 1% of total shares

Companies with high market cap, lower public shareholding

US FDA Warning Letter

Insiders sold stocks

Rising Delivery Percentage Compared to Prev Day

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks